Table 2.
PLK PBD In vitro binding and cellular activity for FLIP compounds (Ncap-S[pT]PNGL)
SCCP ID | Abbreviation | N Capping Group | PLK1 PBD FP IC50 [µM] |
PLK3 PBD FP IC50 [µM] |
Apoptosis @ 24hr, 30 µM |
Aberrant mitoses, @ 24hr, 30 µM |
---|---|---|---|---|---|---|
5594 | 1G1-S[pT]PNGL | ![]() |
350 | ND | ND | ND |
5598 | 1G2-S[pT]PNGL | ![]() |
320 | ND | ND | ND |
5603 | 1G3-S[pT]PNGL | ![]() |
250 | ND | ND | ND |
5756 | 2G1-S[pT]PNGL | ![]() |
99 | ND | ND | ND |
5788 | 3G1-S[pT]PNGL | ![]() |
16.5 | >600 | 36.2% | 47.9% |
5827 | 3G2-S[pT]PNGL | ![]() |
8.6 | >600 | 55.5% | 53.8% |
5743 | Ac-PLHS[pT]A | - | 2 | >600 | 34.0% | 40.3% |